In a letter to DCGI, industry body the Indian Pharmaceutical Alliance (IPA) says companies should be given 30 days’ notice to ...

Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

Rekha Rakesh Jhunjhunwala, through multiple discretionary trusts, owned 25,199,240 equity shares, or 24.09 per cent stake in ...

Trump's choice of vaccine skeptic RFK Jr. for Health Secretary sparks mixed reactions from Republicans and Democrats.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Mankind Pharma announced the pledge of nearly 40 per cent of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited, ...

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

The drug maker reported consolidated net profit from continuing operations of Rs 354.49 crore in Q2 FY25 as against net loss of Rs 180.3 crore in Q2 FY24.

Samir Mehta, Chairman, Torrent Group says both pharma and power businesses have big growth potential. The Pharma business is ...